Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Article Details
- CitationCopy to clipboard
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Science. 1993 Aug 13;261(5123):921-3.
- PubMed ID
- 8346443 [ View in PubMed]
- Abstract
The apolipoprotein E type 4 allele (APOE-epsilon 4) is genetically associated with the common late onset familial and sporadic forms of Alzheimer's disease (AD). Risk for AD increased from 20% to 90% and mean age at onset decreased from 84 to 68 years with increasing number of APOE-epsilon 4 alleles in 42 families with late onset AD. Thus APOE-epsilon 4 gene dose is a major risk factor for late onset AD and, in these families, homozygosity for APOE-epsilon 4 was virtually sufficient to cause AD by age 80.